SANDRA
MUNTION OLAVE
Investigadora desde 2018
Publicaciones (41) Publicaciones de SANDRA MUNTION OLAVE
2023
-
Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease
Nutrients, Vol. 15, Núm. 21
-
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution
eLife, Vol. 12
2022
-
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells
Therapeutic Advances in Hematology, Vol. 13
-
Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia
Frontiers in Bioengineering and Biotechnology, Vol. 10
-
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
Nature Communications, Vol. 13, Núm. 1
2021
-
CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia
CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535
-
Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo
Stem Cell Research and Therapy, Vol. 12, Núm. 1
-
Improving hematopoietic engraftment: Potential role of mesenchymal stromal cell-derived extracellular vesicles
Stem Cells, Vol. 39, Núm. 1, pp. 26-32
-
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
Stem Cell Research and Therapy, Vol. 12, Núm. 1
-
Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease
Nature Communications, Vol. 12, Núm. 1
2019
-
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up
Stem Cell Research and Therapy, Vol. 10, Núm. 1
-
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity
British Journal of Haematology, Vol. 187, Núm. 1, pp. 93-104
-
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability
Stem Cells, Vol. 37, Núm. 10, pp. 1357-1368
2018
-
Biocompatibility of two model elastin-like recombinamer-based hydrogels formed through physical or chemical cross-linking for various applications in tissue engineering and regenerative medicine
Journal of Tissue Engineering and Regenerative Medicine, Vol. 12, Núm. 3, pp. e1450-e1460
-
Human bone marrow mesenchymal stromal cells promote bone regeneration in a xenogeneic rabbit model: A preclinical study
Stem Cells International, Vol. 2018
-
Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 3, pp. 443-451
2017
-
HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: A new therapeutic target?
Oncotarget, Vol. 8, Núm. 17, pp. 28187-28202
-
Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis
PLoS ONE, Vol. 12, Núm. 8
-
Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels
Journal of Materials Science: Materials in Medicine, Vol. 28, Núm. 8
2016
-
Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting
European Journal of Haematology, Vol. 97, Núm. 6, pp. 528-537